Compare Stocks

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	2,500 shs
IMLFF InMed Pharmaceuticals	$0.25 -16.6%	$0.36	$3.04 ▼ $10.63	N/A	N/A	11,369 shs	623,391 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
IMLFF InMed Pharmaceuticals	+10.99%	+0.66%	-15.83%	-16.14%	-74.75%

“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMLFF InMed Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
IMLFF InMed Pharmaceuticals	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
IMLFF InMed Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IMLFF InMed Pharmaceuticals	N/A	-$0.05	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
IMLFF InMed Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
IMLFF InMed Pharmaceuticals	N/A

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
IMLFF InMed Pharmaceuticals	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
IMLFF InMed Pharmaceuticals	4	N/A	N/A	Not Optionable

IMLFF, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog benzinga.com - December 11 at 10:31 AM
	A Guide To The Risks Of Investing In InMed Pharmaceuticals Inc (INM) knoxdaily.com - October 26 at 8:45 AM
	InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference benzinga.com - October 18 at 6:04 PM
	CannabisNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update marketwatch.com - May 16 at 12:01 PM
	InMed Pharmaceuticals Stock Trading Higher On Q3 Sales Growth Of 234%, Here Is What You Need To Know msn.com - May 16 at 12:01 PM
	InMed Pharmaceuticals Stock (NASDAQ:INM), Short Interest Report benzinga.com - March 21 at 7:45 AM
	INM InMed Pharmaceuticals Inc. seekingalpha.com - January 21 at 12:59 AM
	InMed Provides Business Update and Milestones for 2023 technews.tmcnet.com - January 10 at 7:51 AM
	InMed Pharmaceuticals Secures $6M Via Private Placement msn.com - November 22 at 5:19 PM
	InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update benzinga.com - September 23 at 1:16 PM
	InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market yahoo.com - September 13 at 6:26 PM
	InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market finance.yahoo.com - September 9 at 5:35 PM
	InMed Pharmaceuticals Inc.: InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria finanznachrichten.de - August 24 at 6:34 AM
	InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria finance.yahoo.com - August 23 at 8:32 PM
	InMed Pharmaceuticals Closes $5M Direct, Private Placement Offerings apnews.com - June 15 at 1:38 PM
	InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement ... register-herald.com - June 7 at 1:42 AM
	InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - June 6 at 8:42 PM
	InMed Pharmaceuticals (INM): Health and Wellness Product Launches apnews.com - June 1 at 10:21 AM
	How Is The InMed Pharmaceuticals Inc. (NASDAQ: INM) Performance Outlook For The Coming Months? marketingsentinel.com - November 29 at 1:23 PM
	Do InMed Pharmaceuticals Inc.’s (NASDAQ:INM) Prospects Look Stable? stocksregister.com - November 18 at 9:10 AM
	InMed Pharmaceuticals Inc. (NASDAQ: INM) – Analyst View Looks Different Today marketingsentinel.com - November 17 at 2:08 PM
	InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss, Lags Revenue Estimates nasdaq.com - November 10 at 10:54 AM
	DeFi Will End Poorly Without Investor Protections, Gary Gensler Says benzinga.com - October 27 at 2:00 AM
	InMed Pharmaceuticals Inc. (NASDAQ: INM): Don’t Ditch INM Stock In 2021 marketingsentinel.com - October 25 at 1:55 PM

New MarketBeat Followers Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

InMed Pharmaceuticals

OTCMKTS:IMLFF

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, it works on IND-enabling pharmacology and preclinical toxicology studies. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial